Pancreatic human islets and insulin-producing cells derived from embryonic stem cells are rapidly identified by a newly developed Dithizone
- PMID: 31243300
- PMCID: PMC6594947
- DOI: 10.1038/s41598-019-45678-y
Pancreatic human islets and insulin-producing cells derived from embryonic stem cells are rapidly identified by a newly developed Dithizone
Abstract
We developed an optimized Dipheylthiocarbazone or Dithizone (DTZ) with improved physical and chemical properties to characterize human islets and insulin-producing cells differentiated from embryonic stem cells. Application of the newly formulated iDTZ (i stands for islet) over a range of temperatures, time intervals and cell and tissue types found it to be robust for identifying these cells. Through high transition zinc binding, the iDTZ compound concentrated in insulin-producing cells and proved effective at delineating zinc levels in vitro.
Conflict of interest statement
iDTZ is currently being manufactured by Gemini company (Cat #900-755). B.K., M.Q., L.V. and I.H.A. are inventors of iDTZ.
Figures




References
-
- Bakhti, M., Bottcher, A. & Lickert, H. Modelling the endocrine pancreas in health and disease. Nat. Rev. Endocrinol (2018). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical